Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Revolution Medicines

Revolution Medicines
2014 FOUNDED
PRIVATE STATUS
71-80 EMPLOYEES
Series C LATEST DEAL TYPE
$100M LATEST DEAL AMOUNT
15 INVESTORS
Description

Developer of cancer medicines designed to translate frontier cancer targets. The company's medicines are made from natural products that are pharmaceutically optimized analogues of complex natural products that targets proteins that drive the growth of cancers or that control immune responses that can defeat them, enabling patients to get treated safely and without side effects.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 700 Saginaw Drive
  • Redwood City, CA 94063
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Revolution Medicines’s full profile, request a free trial.

Revolution Medicines Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 09-Jul-2019 $100M 00000 00000 Completed Pre-Clinical Trials
2. Early Stage VC (Series B) 23-Mar-2018 0000 00000 00000 Completed Startup
1. Early Stage VC (Series A) 03-Apr-2017 $70M $70M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Revolution Medicines Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series A 70,221,732 $0.000100 6% $1 $1 1x $1 30.45%
To view this company’s complete Cap Table, request access »

Revolution Medicines Competitors (39)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytImmune Venture Capital-Backed Rockville, MD 000.00 0000000000 0 000.00
000000 00000000000 Venture Capital-Backed New York, NY 0000 00000000000 0000
000000 00000000000 Failed Transaction (M&A) Cambridge, MA 000 00000 000000&0
00000000 Angel-Backed Culver City, CA 00000 000000000000 00000
00000 Formerly PE-Backed Paris, France 00 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Revolution Medicines Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000 000 31-Jan-2019 000000000000000000 Drug Discovery 0000 000000000 00.0
To view this company’s complete investment and acquisition history, request access »

Revolution Medicines Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Boxer Capital PE/Buyout Minority 000 0000 000000 0
BVF Partners Hedge Fund Minority 000 0000 000000 0
Cormorant Capital Real Estate Minority 000 0000 000000 0
Deerfield Management Venture Capital Minority 000 0000 000000 0
Fidelity Management & Research Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

Revolution Medicines Executive Team (16)

Name Title Board
Seat
Contact
Info
Mark Goldsmith Ph.D President, Chief Executive Officer and Board Member
Martin Burke MD Scientific Advisory Board Chairman & Co-Founder
Steve Kelsey MD President, Research & Development
Ryan Martins Chief Financial Officer
Margaret Horn JD Chief Operating Officer

4 Former Executives

You’re viewing 5 of 16 executives. Get the full list »

Revolution Medicines Board Members (12)

Name Representing Role Since Contact
Info
Alexis Borisy Third Rock Ventures Board Member 000 0000
Barbara Weber MD Third Rock Ventures Board Member 000 0000
Elizabeth Anderson Self Board Member 000 0000
Kevan Shokat Ph.D Self Co-Founder & Chief Advisory Board Member 000 0000
Laurence Lasky Ph.D The Column Group Board Member 000 0000

3 Former Board Members

You’re viewing 5 of 12 board members. Get the full list »